Healthcare provider profile · identity verified

Evan N Meier, D.O.

Family Practice · GREENDALE, WI · NPI 1629515853

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	565	165
Lisinopril	Lisinopril	335	98
Levothyroxine Sodium	Levothyroxine Sodium	286	76
Losartan Potassium	Losartan Potassium	271	88
Amlodipine Besylate	Amlodipine Besylate	246	79
Hydrochlorothiazide	Hydrochlorothiazide	215	65
Omeprazole	Omeprazole	211	61
Metoprolol Succinate	Metoprolol Succinate	184	55
Metformin Hcl Er	Metformin Hcl	180	56
Tamsulosin Hcl	Tamsulosin Hcl	159	48
Simvastatin	Simvastatin	138	37
Sertraline Hcl	Sertraline Hcl	137	37
Eliquis	Apixaban	121	27
Pantoprazole Sodium	Pantoprazole Sodium	117	41
Trazodone Hcl	Trazodone Hcl	115	37
Gabapentin	Gabapentin	112	43
Rosuvastatin Calcium	Rosuvastatin Calcium	101	33
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	95	24
Furosemide	Furosemide	94	34
Allopurinol	Allopurinol	85	26
Albuterol Sulfate Hfa	Albuterol Sulfate	78	33
Escitalopram Oxalate	Escitalopram Oxalate	72	21
Metformin Hcl	Metformin Hcl	69	20
Pravastatin Sodium	Pravastatin Sodium	66	21
Clopidogrel	Clopidogrel Bisulfate	65	20
Famotidine	Famotidine	65	18
Glipizide Er	Glipizide	61	15
Metoprolol Tartrate	Metoprolol Tartrate	58	13
Jardiance	Empagliflozin	56	20
Alprazolam	Alprazolam	55	20
Tramadol Hcl	Tramadol Hcl	55	21
Meloxicam	Meloxicam	54	16
Duloxetine Hcl	Duloxetine Hcl	52	16
Ozempic	Semaglutide	52	20
Alendronate Sodium	Alendronate Sodium	51	12
Mirtazapine	Mirtazapine	47	suppressed
Potassium Chloride	Potassium Chloride	47	16
Bupropion Xl	Bupropion Hcl	46	13
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	46	16
Valsartan	Valsartan	45	15
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	43	16
Pregabalin	Pregabalin	43	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	41	suppressed
Synthroid	Levothyroxine Sodium	41	11
Fluticasone Propionate	Fluticasone Propionate	39	16
Finasteride	Finasteride	38	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	38	12
Memantine Hcl	Memantine Hcl	37	suppressed
Glimepiride	Glimepiride	36	suppressed
Atenolol	Atenolol	35	14
Citalopram Hbr	Citalopram Hydrobromide	34	11
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	32	suppressed
Clonazepam	Clonazepam	31	suppressed
Montelukast Sodium	Montelukast Sodium	30	suppressed
Trulicity	Dulaglutide	30	suppressed
Prednisone	Prednisone	28	20
Quetiapine Fumarate	Quetiapine Fumarate	26	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	26	suppressed
Diclofenac Sodium	Diclofenac Sodium	25	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	25	suppressed
Ezetimibe	Ezetimibe	24	suppressed
Warfarin Sodium	Warfarin Sodium	24	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	23	suppressed
Lorazepam	Lorazepam	23	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	22	suppressed
Azithromycin	Azithromycin	21	16
Breo Ellipta	Fluticasone/Vilanterol	21	suppressed
Glipizide	Glipizide	21	suppressed
Januvia	Sitagliptin Phosphate	21	suppressed
Xarelto	Rivaroxaban	21	suppressed
Carvedilol	Carvedilol	20	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	20	suppressed
Farxiga	Dapagliflozin Propanediol	20	suppressed
Fenofibrate	Fenofibrate	20	suppressed
Hydrocortisone	Hydrocortisone	20	12
Oxybutynin Chloride	Oxybutynin Chloride	20	suppressed
Aripiprazole	Aripiprazole	19	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	19	15
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	18	18
Diazepam	Diazepam	18	suppressed
Enalapril Maleate	Enalapril Maleate	18	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	18	suppressed
Hydralazine Hcl	Hydralazine Hcl	18	suppressed
Ropinirole Hcl	Ropinirole Hcl	18	suppressed
Spironolactone	Spironolactone	18	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	17	suppressed
Valacyclovir	Valacyclovir Hcl	17	suppressed
Ventolin Hfa	Albuterol Sulfate	17	suppressed
Midodrine Hcl	Midodrine Hcl	16	suppressed
Olanzapine	Olanzapine	16	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	16	suppressed
Ramipril	Ramipril	16	suppressed
Verapamil Er	Verapamil Hcl	16	suppressed
Bumetanide	Bumetanide	15	suppressed
Chlorthalidone	Chlorthalidone	15	suppressed
Benztropine Mesylate	Benztropine Mesylate	14	suppressed
Divalproex Sodium Er	Divalproex Sodium	14	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	14	suppressed
Terazosin Hcl	Terazosin Hcl	14	suppressed
Bydureon Bcise	Exenatide Microspheres	13	suppressed
Dilt-Xr	Diltiazem Hcl	13	suppressed
Donepezil Hcl	Donepezil Hcl	13	suppressed
Fluphenazine Hcl	Fluphenazine Hcl	13	suppressed
Nurtec Odt	Rimegepant Sulfate	13	suppressed
Azelastine Hcl	Azelastine Hcl	12	suppressed
Dulera	Mometasone/Formoterol	12	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	12	suppressed
Humulin 70/30 Kwikpen	Insulin Nph Hum/Reg Insulin Hm	12	suppressed
Mounjaro	Tirzepatide	12	suppressed
Soliqua 100-33	Insulin Glargine/Lixisenatide	12	suppressed
V-Go 40	Sub-Q Insulin Device, 40 Unit	12	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	11	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	11	suppressed
Invokana	Canagliflozin	11	suppressed
Ipratropium Bromide	Ipratropium Bromide	11	suppressed
Levocarnitine	Levocarnitine (With Sugar)	11	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error